Prolonged neutropenia following anti CD20 therapy in a patient with relapsed follicular non-Hodgkin's lymphoma and corrected with IVIG

Ann Oncol. 2001 Oct;12(10):1493-4. doi: 10.1023/a:1012500524758.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / immunology
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Drug Resistance, Neoplasm
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Lymphoma, Follicular / drug therapy*
  • Lymphoma, Follicular / immunology
  • Male
  • Middle Aged
  • Neutropenia / chemically induced*
  • Neutropenia / drug therapy*
  • Recurrence
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Antineoplastic Agents
  • Immunoglobulins, Intravenous
  • Rituximab